| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 3.15e-05 | 5 | 36 | 2 | GO:0052871 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 6.60e-05 | 7 | 36 | 2 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 6.60e-05 | 7 | 36 | 2 | GO:0018685 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 1.41e-04 | 10 | 36 | 2 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 1.41e-04 | 10 | 36 | 2 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 1.41e-04 | 10 | 36 | 2 | GO:0102033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 2.43e-04 | 13 | 36 | 2 | GO:0016713 | |
| GeneOntologyMolecularFunction | arachidonate binding | 3.27e-04 | 15 | 36 | 2 | GO:0050544 | |
| GeneOntologyMolecularFunction | icosanoid binding | 3.73e-04 | 16 | 36 | 2 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 3.73e-04 | 16 | 36 | 2 | GO:0050543 | |
| GeneOntologyMolecularFunction | exonuclease activity | 6.05e-04 | 92 | 36 | 3 | GO:0004527 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 8.51e-04 | 24 | 36 | 2 | GO:0008392 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 9.39e-04 | 107 | 36 | 3 | GO:0033293 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.08e-03 | 27 | 36 | 2 | GO:0008391 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 1.16e-03 | 28 | 36 | 2 | GO:0036041 | |
| GeneOntologyMolecularFunction | aromatase activity | 1.81e-03 | 35 | 36 | 2 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 2.36e-03 | 40 | 36 | 2 | GO:0016709 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 3.52e-03 | 49 | 36 | 2 | GO:0016712 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 3.94e-05 | 6 | 34 | 2 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 5.51e-05 | 7 | 34 | 2 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 7.34e-05 | 8 | 34 | 2 | GO:0036100 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 1.44e-04 | 11 | 34 | 2 | GO:1901523 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.52e-04 | 63 | 34 | 3 | GO:0019228 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 1.72e-04 | 12 | 34 | 2 | GO:0042758 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 2.37e-04 | 14 | 34 | 2 | GO:0097267 | |
| Domain | DUF4704 | 3.21e-05 | 5 | 34 | 2 | PF15787 | |
| Domain | DUF4704 | 3.21e-05 | 5 | 34 | 2 | IPR031570 | |
| Domain | PH_BEACH | 4.80e-05 | 6 | 34 | 2 | PF14844 | |
| Domain | SET | 5.60e-05 | 41 | 34 | 3 | PF00856 | |
| Domain | SET | 7.93e-05 | 46 | 34 | 3 | SM00317 | |
| Domain | PH-BEACH_dom | 8.95e-05 | 8 | 34 | 2 | IPR023362 | |
| Domain | PH_BEACH | 8.95e-05 | 8 | 34 | 2 | PS51783 | |
| Domain | - | 8.95e-05 | 8 | 34 | 2 | 2.30.29.40 | |
| Domain | SET_dom | 1.02e-04 | 50 | 34 | 3 | IPR001214 | |
| Domain | SET | 1.02e-04 | 50 | 34 | 3 | PS50280 | |
| Domain | Beach | 1.15e-04 | 9 | 34 | 2 | PF02138 | |
| Domain | - | 1.15e-04 | 9 | 34 | 2 | 1.10.1540.10 | |
| Domain | BEACH_dom | 1.15e-04 | 9 | 34 | 2 | IPR000409 | |
| Domain | Beach | 1.15e-04 | 9 | 34 | 2 | SM01026 | |
| Domain | BEACH | 1.15e-04 | 9 | 34 | 2 | PS50197 | |
| Domain | RNaseH-like_dom | 2.66e-04 | 69 | 34 | 3 | IPR012337 | |
| Domain | EXOIII | 2.89e-04 | 14 | 34 | 2 | SM00479 | |
| Domain | Exonuclease_RNaseT/DNA_pol3 | 2.89e-04 | 14 | 34 | 2 | IPR013520 | |
| Domain | RNase_T | 2.89e-04 | 14 | 34 | 2 | PF00929 | |
| Domain | Cyt_P450_E_grp-I | 3.03e-03 | 45 | 34 | 2 | IPR002401 | |
| Domain | - | 3.30e-03 | 47 | 34 | 2 | 3.30.420.10 | |
| Domain | Cyt_P450_CS | 4.18e-03 | 53 | 34 | 2 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 4.82e-03 | 57 | 34 | 2 | PS00086 | |
| Domain | - | 4.99e-03 | 58 | 34 | 2 | 1.10.630.10 | |
| Domain | p450 | 4.99e-03 | 58 | 34 | 2 | PF00067 | |
| Domain | Cyt_P450 | 5.33e-03 | 60 | 34 | 2 | IPR001128 | |
| Domain | PH_dom-like | 7.20e-03 | 426 | 34 | 4 | IPR011993 | |
| Domain | ConA-like_dom | 7.28e-03 | 219 | 34 | 3 | IPR013320 | |
| Domain | - | 1.29e-02 | 95 | 34 | 2 | 2.60.120.200 | |
| Domain | WD_REPEATS_1 | 1.39e-02 | 278 | 34 | 3 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.40e-02 | 279 | 34 | 3 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.40e-02 | 279 | 34 | 3 | PS50294 | |
| Pathway | REACTOME_EICOSANOIDS | 1.97e-04 | 12 | 25 | 2 | MM14845 | |
| Pathway | REACTOME_EICOSANOIDS | 1.97e-04 | 12 | 25 | 2 | M27129 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 2.71e-04 | 14 | 25 | 2 | MM15842 | |
| Pathway | REACTOME_FATTY_ACIDS | 3.13e-04 | 15 | 25 | 2 | M27126 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 4.54e-04 | 18 | 25 | 2 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 4.54e-04 | 18 | 25 | 2 | MM14841 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 6.21e-04 | 21 | 25 | 2 | M27137 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 8.83e-04 | 25 | 25 | 2 | MM14858 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 1.03e-03 | 27 | 25 | 2 | M39863 | |
| Pathway | WP_SPHINGOLIPID_PATHWAY | 1.27e-03 | 30 | 25 | 2 | M39501 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 1.54e-03 | 33 | 25 | 2 | MM15963 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 1.54e-03 | 33 | 25 | 2 | MM15918 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.49e-03 | 42 | 25 | 2 | M7169 | |
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 22665481 | ||
| Pubmed | Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. | 6.60e-06 | 4 | 37 | 2 | 11185557 | |
| Pubmed | 1.10e-05 | 5 | 37 | 2 | 22969154 | ||
| Pubmed | Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation. | 1.10e-05 | 5 | 37 | 2 | 21466787 | |
| Pubmed | 1.65e-05 | 6 | 37 | 2 | 9068972 | ||
| Pubmed | 2.30e-05 | 7 | 37 | 2 | 22160543 | ||
| Pubmed | 6.82e-05 | 74 | 37 | 3 | 11157797 | ||
| Pubmed | AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair. | 2.93e-04 | 121 | 37 | 3 | 31900314 | |
| Pubmed | 3.80e-04 | 27 | 37 | 2 | 23096701 | ||
| Pubmed | 7.61e-04 | 686 | 37 | 5 | 28380382 | ||
| Pubmed | 8.72e-04 | 176 | 37 | 3 | 28692057 | ||
| Pubmed | 8.80e-04 | 41 | 37 | 2 | 34638806 | ||
| Pubmed | Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. | 1.01e-03 | 44 | 37 | 2 | 12745259 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 4.28e-04 | 797 | 37 | 5 | chr19p13 | |
| Cytoband | 16p13.3 | 1.01e-03 | 244 | 37 | 3 | 16p13.3 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 6.57e-05 | 9 | 25 | 2 | 1230 | |
| GeneFamily | Cytochrome P450 family 4 | 1.12e-03 | 36 | 25 | 2 | 1003 | |
| ToppCell | 18-Distal-Epithelial-Basal_cell|Distal / Age, Tissue, Lineage and Cell class | 8.83e-06 | 158 | 37 | 4 | 183f445967e09e871c93d8e94781ed9fec894169 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 181 | 37 | 4 | cd46eba2e03fd15d8de8e875793ae2f51fa98b3b | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 181 | 37 | 4 | c7d12c7de227c9433ec2303b8929e957b833f59b | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 184 | 37 | 4 | 1e54fd372c6e6a298f427b807c14cc49aaaffe80 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 8.08e-05 | 220 | 31 | 4 | EFO_0004529, EFO_0008317 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 8.66e-05 | 224 | 31 | 4 | EFO_0004530, EFO_0008317 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 9.43e-05 | 229 | 31 | 4 | EFO_0004639, EFO_0008317 | |
| Disease | very low density lipoprotein cholesterol measurement | 1.54e-04 | 260 | 31 | 4 | EFO_0008317 | |
| Disease | obsolete_red blood cell distribution width | 4.07e-04 | 1347 | 31 | 7 | EFO_0005192 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 5.52e-04 | 153 | 31 | 3 | EFO_0004611, EFO_0020944 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 6.95e-04 | 37 | 31 | 2 | EFO_0022252 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 7.00e-04 | 166 | 31 | 3 | EFO_0004530, EFO_0004611 | |
| Disease | fatty acid measurement | 1.08e-03 | 436 | 31 | 4 | EFO_0005110 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.22e-03 | 49 | 31 | 2 | DOID:3910 (is_implicated_in) | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.48e-03 | 215 | 31 | 3 | EFO_0008317, EFO_0008591 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.62e-03 | 222 | 31 | 3 | EFO_0008317, EFO_0020943 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.66e-03 | 224 | 31 | 3 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 1.68e-03 | 225 | 31 | 3 | EFO_0008317, EFO_0010351 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.68e-03 | 225 | 31 | 3 | EFO_0008317, EFO_0020947 | |
| Disease | triglycerides in IDL measurement | 1.70e-03 | 58 | 31 | 2 | EFO_0022149 | |
| Disease | phospholipids:total lipids ratio | 1.72e-03 | 227 | 31 | 3 | EFO_0020946 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.99e-03 | 239 | 31 | 3 | EFO_0008317, EFO_0020945 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 2.09e-03 | 243 | 31 | 3 | EFO_0004612, EFO_0020944 | |
| Disease | cholesterol in large VLDL measurement | 2.13e-03 | 65 | 31 | 2 | EFO_0021902 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.64e-03 | 264 | 31 | 3 | EFO_0008317, EFO_0020944 | |
| Disease | metabolite measurement | 2.69e-03 | 560 | 31 | 4 | EFO_0004725 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 3.05e-03 | 78 | 31 | 2 | EFO_0022187 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.48e-03 | 291 | 31 | 3 | EFO_0008317, EFO_0020946 | |
| Disease | lipoprotein measurement, phospholipid measurement | 3.61e-03 | 85 | 31 | 2 | EFO_0004639, EFO_0004732 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 4.23e-03 | 312 | 31 | 3 | EFO_0004612, EFO_0010351 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 4.34e-03 | 315 | 31 | 3 | EFO_0004574, EFO_0004612 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 4.40e-03 | 94 | 31 | 2 | EFO_0008595, EFO_0010351 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 4.58e-03 | 321 | 31 | 3 | EFO_0004612, EFO_0004639 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TYYCSRLCRREDWDA | 691 | C9J069 | |
| RWFALDCHERRLLYY | 276 | Q9NPF8 | |
| CESLYDPYRNWRHRI | 156 | Q6ZS30 | |
| PERCAAYAARRAHFW | 96 | Q8TAT2 | |
| DECLSYLCRWIHYRR | 161 | Q5VTA0 | |
| YWSTRYANRRCRYLC | 4586 | Q8NEZ4 | |
| YICHSMAYHRIYRRW | 141 | P49286 | |
| RSHAYYVCAWDRRLA | 281 | Q96S97 | |
| RRVAWSYDCTLLAYA | 136 | A2RRP1 | |
| RHCAYRCYATWRFGS | 546 | Q99572 | |
| DACYRYDPHLNRWLR | 381 | Q53HC5 | |
| HYALCRYAEWEERIS | 446 | Q9HCG7 | |
| AWTYAFYHNGRRLRC | 36 | P98187 | |
| RDQLCYYHWGRVRSS | 431 | Q8IX06 | |
| IACRDLFQDTYHRYW | 506 | Q96D53 | |
| AWTYAFYDNCRRLRC | 36 | P78329 | |
| GRRYNCYKHHWSDSR | 111 | O75165 | |
| TVDYCHSYELFNRRW | 56 | Q6WQI6 | |
| LVSFRYHCRLYNEWR | 201 | Q86UD3 | |
| RTDYYLRRRHWAFGD | 71 | Q9BXC0 | |
| AQCRAAHYRWVRRKY | 1471 | O95180 | |
| FDRCYERGLAWYRSL | 126 | Q96QI5 | |
| WRATRDMCRYRHNYP | 66 | Q9NZT2 | |
| CRYEIEWITEYACHR | 306 | P11717 | |
| DEECYYHWGRLRRNR | 991 | Q8N1G1 | |
| WSCHWDRDHRRYFYV | 601 | Q8N3X1 | |
| VHIYNRWRNSEIRCY | 331 | Q8NFP9 | |
| RDHPTLCISLYRYWR | 476 | Q8NA58 | |
| QGHCYRYFAHRRAWE | 1096 | O14594 | |
| LLVWYCRDFAERLHY | 196 | O75626 | |
| EVDRRWYFYRHRSCP | 181 | O75783 | |
| QCTYREELRDHRKYW | 36 | Q6UXG3 | |
| YLRDFLRYWRIEKCH | 86 | O15270 | |
| VRFYYLDEHRSCIRW | 66 | O75038 | |
| CFLHRLISALRYYWD | 556 | Q5XPI4 | |
| RCDPISEHNRLYWYR | 41 | P04435 | |
| WNALYRYRACDHCLR | 61 | Q6GMV2 |